Yanoyan, Leonilo J.
HRN: 13-98-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/22/2022
05/29/2022
IV
1.5g
Q6H
Gangrenous Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes